NCT03454711

Brief Summary

Identification of the cerebral fMRI phenotype of obese patients with FA in cognitive task context based on food choice making

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for phase_2 obesity

Timeline
Completed

Started Apr 2018

Typical duration for phase_2 obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 6, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

April 26, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2021

Completed
Last Updated

August 1, 2023

Status Verified

May 1, 2023

Enrollment Period

3.4 years

First QC Date

February 20, 2018

Last Update Submit

July 27, 2023

Conditions

Keywords

ObesityFood addictionsFunctional magnetic resonance imaging (fMRI)Metabolomics

Outcome Measures

Primary Outcomes (1)

  • Significant change in brain activity of the prefrontal cortex (area involved in the inhibitory control of food intake) measured by modification of BOLD (Blood-Oxygen-Level-Dependent) signal in fMRI during a cognitive task based on food choice making

    Month 2

Study Arms (2)

Patient with food addcitions

EXPERIMENTAL

Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire. Three clinical visits will be realized in less than two months

Device: fMRIDevice: Indirect calorimetryDevice: BioimpedanceBiological: Lipid profile, glucose, HBA1c, metabolomic analysisBehavioral: YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)

Patients without food addictions

EXPERIMENTAL

Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire. Three clinical visits will be realized in less than two months

Device: fMRIDevice: Indirect calorimetryDevice: BioimpedanceBiological: Lipid profile, glucose, HBA1c, metabolomic analysisBehavioral: YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)

Interventions

fMRIDEVICE

Brain MRI

Patient with food addcitionsPatients without food addictions

Resting energy expenditure

Patient with food addcitionsPatients without food addictions

Measurement of body composition

Patient with food addcitionsPatients without food addictions

Blood sample

Patient with food addcitionsPatients without food addictions

Questionnaires to characterize eating habits and depression

Patient with food addcitionsPatients without food addictions

Eligibility Criteria

Age30 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • female
  • right-handed
  • grade 1 and 2 obesity
  • aged between 20 and 50
  • no other addictions including smoking
  • no contraindications to fMRI
  • affiliated to French Social Security
  • having given a written informed consent

You may not qualify if:

  • abdominal circumference + upper limbs along the body \> 200cm
  • addiction to alcohol or other psychoactive substances
  • daily smoker
  • sleep Apnea Syndrome paired
  • psychotic psychiatric disorders
  • history of bariatric surgery
  • medical care in the nutrition unit
  • inability to comprehend or complete questionnaires
  • pregnant or breastfeeding woman
  • persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35033, France

Location

MeSH Terms

Conditions

ObesityFood Addiction

Interventions

Magnetic Resonance ImagingCalorimetry, IndirectGlucoseWeights and Measures

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AddictiveCompulsive BehaviorImpulsive BehaviorBehaviorFeeding and Eating DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisCalorimetryChemistry Techniques, AnalyticalInvestigative TechniquesHexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • David Val-Laillet, MSc, PhD, HDR

    Institut NuMeCan, INRA 1341, INSERM 1241, Université de Rennes 1

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2018

First Posted

March 6, 2018

Study Start

April 26, 2018

Primary Completion

September 8, 2021

Study Completion

September 8, 2021

Last Updated

August 1, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations